Company intelligence / Profile preview

VLP Therapeutics Japan

Minato-ku, Tokyo, Japanvlptherapeutics.co.jp ↗
Ownership
Private
Development stage
Other
01

Overview

VLP Therapeutics Japan is developing self-amplifying RNA (replicon) and VLP-based prophylactic vaccines for infectious diseases, with its COVID-19 self-amplifying RNA vaccine having reached Phase 3 globally via the VLP group, and a Phase 1 booster study of the next‑generation candidate VLPCOV-02 in Japanese adults showing favorable safety and immunogenicity compared with the earlier VLPCOV-01 construct.[5][6]

Therapeutic areas
Infectious Diseases
Modalities
mRNA-based drugsVaccineLipid nanoparticle delivery therapyRNA therapy
Industry
Biotech
02

Drug pipeline

10 assets

replicon RNA COVID-19 vaccine

Preclinical

9 more assets in the full pipeline.

03

Partnerships

Sojitz CorporationJapan Agency for Medical Research and Development (AMED)Japanese Ministry of Health, Labour and WelfareJapanese Ministry of Economy, Trade and IndustryNational Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)National Hospital Organization Nagoya Medical CenterHokkaido University

Beyond the preview

Go deeper on VLP Therapeutics Japan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VLP Therapeutics Japan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call